Search This Blog

Friday, February 28, 2020

Cellular Biomedicine EPS beats by $0.08

Cellular Biomedicine (NASDAQ:CBMG): FY GAAP EPS of -$2.63 beats by $0.08.
Cash, cash equivalents and restricted cash of $32.4M
Press Release
https://seekingalpha.com/news/3547178-cellular-biomedicine-eps-beats-0_08
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)